Galena Biopharma Inc


Wednesday’s Market Insights: DryShips Inc. (DRYS), Gilead Sciences, Inc. (GILD) and Galena Biopharma (GALE)

DryShips Inc. (NASDAQ:DRYS) stock is sinking by 16% in Tuesday’s trading session, after the controversial shipping company reported a serious loss in its …

Here’s Why Galena Biopharma Inc (GALE) Stock Is Falling 18%

Galena Biopharma Inc (NASDAQ:GALE) investors are heading for the hills after the small biotech firm announced it has commenced an underwritten public offering, subject …

FBR Downgrades Galena Biopharma Inc (GALE) Right as Stock Skyrockets 30%

This morning, the firm revealed an independent group of experts has judged its breast cancer combination treatment of NeuVax with chemotherapy drug trastuzumab in …

Galena Biopharma Inc (GALE) Announces Positive DSMB Recommendation for Breast Cancer Treatment; Maxim Cautious

Investors in Galena Biopharma Inc (NASDAQ:GALE) are having a great morning today. Galena shares are up over 50% after the biotech company announced that the …

This Analyst Has Had Enough with Galena Biopharma Inc (GALE)

Investors weren’t impressed with Galena Biopharma Inc (NASDAQ:GALE) latest announcement that CEO Dr. Mark Schwartz’s would stand down, and at least one analyst …

Company Update (NASDAQ:GALE): Galena Biopharma Inc Announces the Resignation of CEO Mark W. Schwartz and the Evaluation of Strategic Alternatives

Galena Biopharma Inc (NASDAQ:GALE) announced that the Board of Directors has entered into a separation agreement with Mark W. Schwartz, Ph.

Monday’s Healthcare News: AMAG Pharmaceuticals, Inc. (AMAG), Galena Biopharma Inc (GALE), Ariad Pharmaceuticals, Inc. (ARIA)

Today’s healthcare sector offered a great deal of rumble and tumble with the following volatile stocks making headlines today: AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG), …

Stock Update (NASDAQ:GALE): Galena Biopharma Inc Provides Update on Abstral Investigation

As previously disclosed, on December 16, 2015, Galena Biopharma Inc (NASDAQ:GALE) received a subpoena issued by the U.S.

Company Update (NASDAQ:GALE): Galena Biopharma Inc Confirms Regulatory Pathway for GALE-401 into Phase 3 Trial

Galena Biopharma Inc (NASDAQ:GALE) announced the Company has confirmed the regulatory pathway to advance GALE-401 (Anagrelide Controlled Release) into a pivotal, Phase 3 …

Company Update (NASDAQ:GALE): Galena Biopharma Inc Announces the Phase 2 Clinical Trial of NeuVax in Ductal Carcinoma in Situ (DCIS) Open for Enrollment and Screening Patients

Galena Biopharma Inc (NASDAQ:GALE) announced that the NeuVax (nelipepimut-S) Phase 2 clinical trial entitled “VADIS: Phase 2 trial of the Nelipepimut-S Peptide Vaccine …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts